InsiderSignalSign in

SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

$ZSTK

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

COPIED JUL 21

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

4 h delay
BuysSellsBuys and sellsAny size$100K+$1M+
Pro filters
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.5M−2.8%3d ago
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.3M−2.8%4d ago
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.3M−2.8%5d ago
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.2M−2.8%6d ago
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.1M−2.8%Oct 19
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.2M−2.8%Oct 16
UTHRSell

UNITED THERAPEUTICS Corp

Paul A Mahon · EVP and General Counsel

$4.5M−15.5%Oct 16
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.1M−2.8%Oct 15
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.2M−2.8%Oct 14
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.2M−2.8%Oct 13
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.2M−2.8%Oct 13
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.1M−2.8%Oct 9
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.2M−2.8%Oct 8
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.1M−2.8%Oct 7
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.1M−2.8%Oct 6
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.2M−2.8%Oct 5
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.5M−2.8%Oct 2
UTHRSell

UNITED THERAPEUTICS Corp

Paul A Mahon · EVP and General Counsel

$4.7M−15.5%Oct 1
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$1.1M−0.6%Oct 1
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$3.9M−2.3%Oct 1
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.5M−2.8%Sep 30
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.6M−2.8%Sep 29
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.5M−2.8%Sep 28
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.5M−2.8%Sep 25
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.7M−2.8%Sep 24
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.7M−2.8%Sep 23
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.7M−2.8%Sep 22
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.7M−2.8%Sep 21
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.7M−2.8%Sep 18
UTHRSell

UNITED THERAPEUTICS Corp

Paul A Mahon · EVP and General Counsel

$4.1M−15.5%Sep 18
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.8M−2.8%Sep 17
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.8M−2.8%Sep 16
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.8M−2.8%Sep 15
UTHRSell

UNITED THERAPEUTICS Corp

Nilda Mesa · Director

$115K−3.9%Sep 15
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.8M−2.8%Sep 14
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.8M−2.8%Sep 11
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.8M−2.8%Sep 10
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.7M−2.8%Sep 9
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.6M−2.8%Sep 8
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.6M−2.8%Sep 4
UTHRSell

UNITED THERAPEUTICS Corp

Paul A Mahon · EVP and General Counsel

$4.0M−15.5%Sep 3
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.7M−2.8%Sep 3
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.9M−2.8%Sep 2
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.9M−2.8%Sep 1
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.9M−2.8%Aug 31
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$5.0M−2.8%Aug 28
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.9M−2.8%Aug 27
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.9M−2.8%Aug 26
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.9M−2.8%Aug 25
UTHRSell

UNITED THERAPEUTICS Corp

Martine A Rothblatt · Chair and CEO

$4.9M−2.8%Aug 24
Older filings

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.